Exicure (NASDAQ:XCUR) Announces Quarterly Earnings Results

Exicure (NASDAQ:XCUR) posted its quarterly earnings data on Tuesday. The company reported ($3.39) earnings per share (EPS) for the quarter, Zacks reports.

Exicure Stock Performance

Shares of XCUR stock traded down $0.36 during trading hours on Tuesday, reaching $12.63. The company had a trading volume of 34,819 shares, compared to its average volume of 567,374. Exicure has a 12-month low of $1.44 and a 12-month high of $36.00. The company has a market capitalization of $32.91 million, a price-to-earnings ratio of -6.10 and a beta of 3.84. The stock has a fifty day moving average of $10.28 and a 200-day moving average of $9.31.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.